2016NCCN指南变迁解读.pptxVIP

2016 NCCN GuidelinesAcute Myeloid LeukemiaNCCN AML 2016 V1目录AML-1 / EVALUATION FOR ACUTE LEUKEMIAAML-2 / APL CLASSIFICATIONAML-3 / TREATMENT INDUCTION (HIGH RISK)AML-4 / TREATMENT INDUCTION (LOW RISK)AML-5 / APL POST-CONSOLIDATION MONITORINGAML-6 / APL-THERAPY FOR RELAPSEAML-7/ AML CLASSIFICATIONAML-8 / AML POST-INDUCTION THERAPY AFTER STANDARD-DOSE CYTARABINE, 60yAML-9 / AML POST-INDUCTION THERAPY AFTER HIGH-DOSE CYTARABINE, 60yAML-10 / POST-REMISSION THERAPY, 60yAML-11 / AML ≥ 60yPS评分被替换AML-12 / AML POST-INDUCTION THERAPY AFTER STANDARD-DOSE CYTARABINE, ≥ 60yAML-13 / POST-REMISSION THERAPY,